What does the subordinating conjunction because indicate? a. a reason, a cause, or an effect b. ...

Author Question: What does the subordinating conjunction because indicate? a. a reason, a cause, or an effect b. ... (Read 52 times)

michelleunicorn

Hero Member
Posts: 565

on: Jul 15, 2018

What does the subordinating conjunction because indicate?

a. a reason, a cause, or an effect
b. a condition or result
c. a location
d. a point in time
e. to contrast ideas

Question 2

Which subordinating conjunction would best join these sentences? I am not going mountain-
biking you can promise I won't get hurt.

a. though
b. unless
c. whereas
d. as if
e. whether

hugthug12

Sr. Member
Posts: 329

Reply #1 on: Jul 15, 2018

Answer to Question 1

a

Answer to Question 2

b

Need homework help now?

Ask unlimited questions for free

Ask a Question

« previous next »

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

The word drug comes from the Dutch word droog (meaning "dry"). For centuries, most drugs came from dried plants, hence the name.

Did you know?

A strange skin disease referred to as Morgellons has occurred in the southern United States and in California. Symptoms include slowly healing sores, joint pain, persistent fatigue, and a sensation of things crawling through the skin. Another symptom is strange-looking, threadlike extrusions coming out of the skin.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.